Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 465
interventional 431
Observational 32
Registry 2

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 234
Drug|Radiation 31
Biological|Drug 28
Drug|placebo 23
Radiation 22
Biological 17
Drug|Other 15
Drug|Procedure 8
Biological|Drug|Radiation 7
Biological|Drug|Other 5
Other 4
Procedure 4
Combination Product 2
Device 2
Device|Drug 2
Drug|Other|placebo 2
Drug|Other|Procedure 2
Drug|Other|Radiation 2
Drug|Procedure|Radiation 2
Other|Procedure 2
Other|Radiation 2
Behavioral|Drug|Other|Procedure 1
Behavioral|Other|Procedure 1
Biological|Drug|Other|Procedure 1
Biological|Drug|placebo 1
Biological|Other 1
Biological|placebo 1
Biological|Radiation 1
Combination Product|Drug 1
Device|Other 1
Device|Radiation 1
Diagnostic Test 1
Dietary Supplement|Drug|placebo 1
Drug|Other|Procedure|Radiation 1
placebo 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 204
China 46
Korea, Republic of 17
United States|Canada 16
NA 12
Canada 11
France 7
Japan 7
United Kingdom 7
United States|United Kingdom 4
Denmark 3
Germany 3
Italy 3
Spain 3
Switzerland 3
Greece 2
Netherlands 2
United States|Canada|Russian Federation 2
United States|Poland 2
Argentina|Australia|Belgium|Brazil|France|Germany|Hungary|Italy|Mexico|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
Austria|Belgium|Czech Republic|Egypt|France|Germany|Italy|Netherlands|Poland|Russian Federation|Spain|Switzerland|Taiwan 1
Austria|Belgium|Germany|Spain 1
Austria|Germany 1
Belgium 1
Belgium|Cyprus|Egypt|France|Germany|Hungary|Israel|Italy|Netherlands|Poland|Turkey|United Kingdom 1
Belgium|France|Greece|Spain 1
Belgium|Italy|Netherlands|Poland|United Kingdom 1
Belgium|Netherlands 1
Bosnia and Herzegovina|Croatia|Poland|Serbia|Spain 1
Bulgaria|Hungary|Netherlands|Russian Federation|Ukraine|United Kingdom 1
Denmark|Lithuania|Norway|Sweden|Switzerland 1
Denmark|Norway|Poland|Romania|Sweden 1
Denmark|Norway|Sweden 1
Denmark|United Kingdom 1
Egypt|France|Italy|United Kingdom 1
France|Italy|Spain 1
Germany|Australia|Belgium|France|Netherlands|Spain|Switzerland|United Kingdom 1
Germany|Hungary|Poland|Spain|Ukraine 1
Germany|Italy 1
Germany|United States|Australia|Austria|Belgium|Brazil|Chile|China|Czechia|Denmark|France|Greece|Hungary|Israel|Italy|Japan|Korea, Republic of|Norway|Poland|Romania|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
Germany|United States|Australia|Belgium|Bulgaria|Canada|Chile|Czechia|France|Greece|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Serbia|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
Italy|United States|France|Germany|India|Poland|Russian Federation|Ukraine 1
Japan|Korea, Republic of 1
Lebanon|United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Czechia|France|Germany|Greece|Hungary|Italy|Netherlands|Poland|Portugal|Romania|Spain|United Kingdom 1
Poland 1
Spain|United Kingdom 1
Spain|United States|Switzerland 1
Sweden 1
Taiwan 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Czechia|France|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Portugal|Romania|Russian Federation|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Colombia|Finland|France|Germany|Greece|Hong Kong|Ireland|Israel|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Peru|Poland|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|China|France|Germany|Greece|Hungary|India|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Portugal|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Taiwan|Turkey|United Kingdom 1
United States|Argentina|Austria|Brazil|Bulgaria|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Slovakia|Spain|Taiwan|Turkey|Ukraine 1
United States|Argentina|Belgium|Canada|China|Czechia|Germany|India|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Taiwan|Turkey|Vietnam 1
United States|Australia|Austria|Belgium|Brazil|Czechia|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Singapore|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Netherlands|Poland|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Germany|Netherlands|New Zealand|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Brazil|Chile|China|Czechia|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Serbia|Spain|Taiwan|United Kingdom 1
United States|Australia|Belarus|Belgium|Brazil|Bulgaria|Canada|China|Croatia|Czechia|Denmark|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Latvia|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belgium|Brazil|Chile|China|Colombia|Cyprus|Czech Republic|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Lithuania|Macedonia, The Former Yugoslav Republic of|Netherlands|Poland|Portugal|Romania|Serbia|South Africa|Spain|Switzerland|Turkey|United Kingdom 1
United States|Australia|Belgium|Brazil|China|France|Germany|Hungary|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Spain|Taiwan|Turkey|Ukraine 1
United States|Australia|Belgium|Canada|Czechia|France|Hungary|Korea, Republic of|Netherlands|Romania|Russian Federation|Spain 1
United States|Australia|Belgium|Canada|Korea, Republic of|Netherlands|Puerto Rico 1
United States|Australia|Bulgaria|Canada|France|Georgia|Hong Kong|Hungary|India|Italy|Korea, Republic of|Lithuania|Malaysia|Philippines|Poland|Romania|Russian Federation|Slovakia|Spain|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Australia|Canada|Chile|France|Germany|Hungary|Ireland|Israel|Japan|Korea, Republic of|New Zealand|Poland|Russian Federation|Spain|Switzerland|Taiwan|Turkey|United Kingdom 1
United States|Australia|Canada|France|Ireland 1
United States|Australia|France|Germany|Japan|Netherlands|Spain|United Kingdom 1
United States|Australia|Korea, Republic of|Taiwan 1
United States|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Costa Rica|Czech Republic|Estonia|Finland|France|Germany|Honduras|Hungary|Italy|Jamaica|Korea, Republic of|Lithuania|Mexico|Netherlands|New Zealand|Norway|Panama|Poland|Puerto Rico|Russian Federation|Singapore|Slovakia|South Africa|Spain|Taiwan|United Kingdom 1
United States|Belgium|Bosnia and Herzegovina|Croatia|North Macedonia|Serbia|Slovakia|Slovenia 1
United States|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Spain 1
United States|Belgium|France|Japan|Korea, Republic of|Spain|Turkey|United Kingdom 1
United States|Brazil|Canada|Chile|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Norway|Poland|Romania|Russian Federation|Spain|Ukraine 1
United States|Bulgaria|Canada|Czech Republic|Hungary|India|Poland|Romania|Serbia|United Kingdom 1
United States|Bulgaria|Estonia|France|Latvia|Spain|Ukraine 1
United States|Canada|Denmark|France|Spain 1
United States|Canada|Israel 1
United States|Canada|Japan|Korea, Republic of 1
United States|Canada|Puerto Rico 1
United States|Canada|United Kingdom 1
United States|Denmark|France|Korea, Republic of|Netherlands|New Zealand|Spain 1
United States|Denmark|Korea, Republic of 1
United States|France 1
United States|France|Georgia|Hungary|Moldova, Republic of|Poland|Spain 1
United States|France|Germany|Greece|Korea, Republic of|Netherlands|Spain|Turkey|Ukraine|United Kingdom 1
United States|France|Spain 1
United States|Israel|Korea, Republic of|Puerto Rico 1
United States|Italy|Russian Federation|Spain 1
United States|Japan|Korea, Republic of|Spain|Taiwan 1
United States|Korea, Republic of|Romania 1
United States|Netherlands 1
United States|Netherlands|United Kingdom 1
United States|Puerto Rico 1
United States|Russian Federation|Ukraine 1
United States|Singapore 1
United States|Spain 1

Sites per Study

Site_count Study_Count
1 174
2 22
3 19
4 14
5 12
6 8
7 8
8 11
9 5
10 8
11 6
12 6
13 5
14 6
15 6
16 7
17 6
18 5
19 6
20 4
21 4
22 2
23 1
24 2
25 3
26 3
28 1
29 1
31 1
33 2
34 1
37 1
38 1
39 1
40 2
41 1
45 1
46 1
47 1
48 1
49 2
50 2
51 2
53 1
55 1
58 1
60 1
61 2
62 1
68 1
72 1
73 1
75 1
76 1
77 1
78 1
79 2
83 1
84 1
85 2
86 1
87 1
91 1
93 1
102 1
104 1
115 2
125 1
140 1
141 1
147 1
148 2
149 1
160 1
176 1
190 1
195 1
196 1
203 1
204 1
205 1
222 1
225 1
226 1
257 1
262 1
276 1
301 1
329 1
408 1
428 1
508 1
781 1
934 1

Phase

Phase Study_Count
Phase 2 199
Phase 1 84
Phase 1/Phase 2 61
Phase 3 52
N/A 24
Phase 2/Phase 3 9
Early Phase 1 1
Phase 4 1

Number of Arms

Number_of_Arms Count_of_Studies
1 191
2 126
3 31
4 11
5 1
6 9
7 3
8 2
10 1
12 1
17 1
NA 54

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 6 13.0000 1.000 9.0000 2.00000 40.0000 4.0000 1000
1st Qu. 6 40.5000 17.750 40.0000 35.00000 143.0000 368.0000 1000
Median 6 96.5000 30.000 82.0000 60.00000 313.0000 489.0000 1000
Mean 6 152.1667 56.575 107.6393 81.60104 313.6667 505.6275 1000
3rd Qu. 6 204.7500 66.000 156.0000 92.00000 480.0000 625.0000 1000
Max. 6 547.0000 360.000 515.0000 611.00000 506.0000 1351.0000 1000

Trial Group Type

group_type Group_Count
Experimental 571
Active Comparator 100
NA 54
Placebo Comparator 21
Other 15
No Intervention 8

Intervention Model

intervention_model Study_Count
Single Group Assignment 219
Parallel Assignment 155
NA 25
Sequential Assignment 21
Crossover Assignment 9
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 409
Supportive Care 11
Prevention 4
Diagnostic 3
Other 2
Health Services Research 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 13
NA 4
Korea, Republic of 3
Canada 2
Argentina|Austria|Belgium|Brazil|Bulgaria|Colombia|Croatia|Egypt|France|Hungary|Israel|Italy|Lebanon|Lithuania|Mexico|Netherlands|Philippines|Poland|Portugal|Romania|Slovenia|Spain|United Arab Emirates|United Kingdom 1
Austria|Czech Republic|Estonia|France|Germany|Greece|Hungary|Italy|Korea, Republic of|Lithuania|Netherlands|Poland|Slovenia|Spain 1
China 1
Denmark 1
Germany 1
Japan 1
Kazakhstan 1
Mexico 1
Netherlands 1
Spain 1

Sites per Study

Site_count Study_Count
1 22
2 3
3 1
18 1
32 1
46 1
61 1
187 1
247 1

Enrollment Metrics

Measure Observational
Min 12.0
1st Qu 50.5
Median 179.5
Mean 494.5
3rd Qu 511.5
Max 3000.0

Observation Model

observational_model Study_Count
Cohort 18
Case-Only 7
NA 3
Case-Control 2
Other 2

Time Perspective

time_perspective Study_Count
Prospective 25
Retrospective 5
NA 2

Registries

Studies by Country

Country Study_Count
Germany 1
United States 1

Sites per Study

Site_count Study_Count
1 2

Enrollment Metrics

Measure Registries
Min 200
1st Qu 2025
Median 3850
Mean 3850
3rd Qu 5675
Max 7500

Registry Model

observational_model Study_Count
Cohort 1
Other 1

Time Perspective

time_perspective Study_Count
Other 1
Prospective 1

Follow-up

target_duration Study_Count
10 Years 1
3 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03345485 Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03345485 Active, not recruiting Mundipharma-EDO GmbH 2021-12-31
NCT04334941 Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker https://ClinicalTrials.gov/show/NCT04334941 Recruiting National Cancer Institute (NCI) 2025-11-30
NCT02394548 Phase I Trial Of IMRT Using A Contralateral Esophagus Sparing Technique (CEST) In Locally Advanced Lung Cancer https://ClinicalTrials.gov/show/NCT02394548 Active, not recruiting Massachusetts General Hospital 2019-02-28
NCT04032704 A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04032704 Recruiting Seattle Genetics, Inc. 2021-07-31
NCT03923270 Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03923270 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2024-05-01
NCT03811002 Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03811002 Recruiting National Cancer Institute (NCI) 2026-12-28
NCT03649841 Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer https://ClinicalTrials.gov/show/NCT03649841 Recruiting University of Washington 2022-09-16
NCT03410368 NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer. https://ClinicalTrials.gov/show/NCT03410368 Recruiting First Hospital of Jilin University 2019-06-01
NCT03406715 Combination Immunotherapy-Ipilimumab-Nivolumab-Dendritic Cell p53 Vac - Patients With Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT03406715 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2021-04-30
NCT03391362 Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-6 Brain Metastases https://ClinicalTrials.gov/show/NCT03391362 Recruiting Dana-Farber Cancer Institute 2021-06-30
NCT03382561 Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03382561 Active, not recruiting National Cancer Institute (NCI) 2021-06-02
NCT03371979 Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03371979 Active, not recruiting Aeglea Biotherapeutics 2020-12-31
NCT03365791 PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies https://ClinicalTrials.gov/show/NCT03365791 Active, not recruiting Novartis 2019-02-21
NCT03823118 S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT03823118 Recruiting Taizhou Hospital 2020-02-28
NCT03333616 Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors https://ClinicalTrials.gov/show/NCT03333616 Recruiting Dana-Farber Cancer Institute 2021-05-31
NCT03325816 Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03325816 Active, not recruiting Georgetown University 2019-03-28
NCT03319940 Study Evaluating Safety, Tolerability and PK of AMG 757 in Adults With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03319940 Recruiting Amgen 2022-08-07
NCT03305341 Discovery Stage IND EXEMPT NDA Clinical Research - Etoposide OS and Single Nucleotide Polymorphisms https://ClinicalTrials.gov/show/NCT03305341 Active, not recruiting Medicine Invention Design, Inc 2020-04-08
NCT03297424 A Study of PLX2853 in Advanced Malignancies. https://ClinicalTrials.gov/show/NCT03297424 Recruiting Plexxikon 2020-12-31
NCT03262454 Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLC https://ClinicalTrials.gov/show/NCT03262454 Recruiting National Cancer Center, Korea 2019-12-31
NCT03239171 Bioinformation Therapy for Lung Cancer https://ClinicalTrials.gov/show/NCT03239171 Completed Fuda Cancer Hospital, Guangzhou 2018-09-02
NCT03228667 QUILT-3.055: A Study of ALT-803 in Combination With PD-1/PD-L1 Checkpoint Inhibitor in Patients With Advanced Cancer https://ClinicalTrials.gov/show/NCT03228667 Recruiting Altor BioScience 2021-06-30
NCT03227016 Study in Patients With SCLC of Veliparib in Combination With Topotecan https://ClinicalTrials.gov/show/NCT03227016 Recruiting Central European Society for Anticancer Drug Research 2020-12-31
NCT03223155 Concurrent or Sequential Immunotherapy and Radiation Therapy in Patients With Metastatic Lung Cancer https://ClinicalTrials.gov/show/NCT03223155 Recruiting University of Chicago 2020-12-31
NCT03221400 PEN-866 in Patients With Advanced Solid Malignancies https://ClinicalTrials.gov/show/NCT03221400 Recruiting Tarveda Therapeutics 2021-12-31
NCT03214003 Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC https://ClinicalTrials.gov/show/NCT03214003 Enrolling by invitation Beijing Cancer Hospital 2020-05-31
NCT03154190 Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer https://ClinicalTrials.gov/show/NCT03154190 Recruiting Stanford University 2020-11-30
NCT03098030 Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03098030 Completed United Therapeutics 2020-01-27
NCT03092934 A Study of AK-01 (LY3295668) in Solid Tumors https://ClinicalTrials.gov/show/NCT03092934 Active, not recruiting Eli Lilly and Company 2019-12-01
NCT03088813 Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03088813 Recruiting Ipsen 2022-09-30
NCT03086239 A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03086239 Completed AbbVie 2018-01-30
NCT03085849 SGI-110 Plus Durvalumab/Tremelimumab in SCLC https://ClinicalTrials.gov/show/NCT03085849 Completed Columbia University 2018-11-26
NCT03083691 BIOLUMA: Biomarkers for Nivolumab and Ipilimumab and Evaluation of the Combination in Lung Cancer https://ClinicalTrials.gov/show/NCT03083691 Enrolling by invitation Lung Cancer Group Cologne 2020-03-31
NCT03080311 A Study of APG-1252 in Patients With SCLC or Other Solid Tumors https://ClinicalTrials.gov/show/NCT03080311 Active, not recruiting Ascentage Pharma Group Inc. 2020-06-12
NCT03077854 Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial https://ClinicalTrials.gov/show/NCT03077854 Recruiting National Taiwan University Hospital 2021-05-31
NCT03066778 A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) https://ClinicalTrials.gov/show/NCT03066778 Active, not recruiting Merck Sharp & Dohme Corp. 2019-12-18
NCT03061812 Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE) https://ClinicalTrials.gov/show/NCT03061812 Completed AbbVie 2020-02-12
NCT03059797 Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202) https://ClinicalTrials.gov/show/NCT03059797 Completed Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 2018-06-30
NCT03059667 Immunotherapy as Second-line in Patient With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03059667 Active, not recruiting Intergroupe Francophone de Cancerologie Thoracique 2018-09-10
NCT03043872 Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) https://ClinicalTrials.gov/show/NCT03043872 Active, not recruiting AstraZeneca 2020-01-27
NCT03043599 Ipilimumab + Nivolumab w/Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03043599 Active, not recruiting H. Lee Moffitt Cancer Center and Research Institute 2018-10-26
NCT03041311 Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Extensive Stage Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT03041311 Active, not recruiting G1 Therapeutics, Inc. 2018-07-28
NCT03009682 Olaparib Monotherapy in Relapsed Small Cell Lung Cancer Patients With HR Pathway Gene Mutations Not Limited to BRCA 1/2 Mutations, ATM Deficiency or MRE11A Mutations https://ClinicalTrials.gov/show/NCT03009682 Recruiting Samsung Medical Center 2021-09-30
NCT02995902 FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02995902 Completed Rigshospitalet, Denmark 2017-02-08
NCT02995889 FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer https://ClinicalTrials.gov/show/NCT02995889 Active, not recruiting Rigshospitalet, Denmark 2019-02-07
NCT02978404 Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases https://ClinicalTrials.gov/show/NCT02978404 Active, not recruiting Centre hospitalier de l’Université de Montréal (CHUM) 2021-06-30
NCT02963090 Pembrolizumab vs Topotecan in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02963090 Active, not recruiting Alliance Foundation Trials, LLC. 2019-05-20
NCT02949895 Study of BMS-986012 in Subjects With Small Cell Lung Caner https://ClinicalTrials.gov/show/NCT02949895 Completed Bristol-Myers Squibb 2017-08-29
NCT02937818 A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02937818 Active, not recruiting AstraZeneca 2020-06-18
NCT02936323 PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers https://ClinicalTrials.gov/show/NCT02936323 Active, not recruiting Tarveda Therapeutics 2020-07-31
NCT02934503 Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT02934503 Recruiting NYU Langone Health 2019-10-31
NCT02913443 A Dose Finding and Expansion Study of RO7051790 Administered Orally in Participants With Relapsed, Extensive-Stage Disease Small Cell Lung Cancer (ED SCLC) https://ClinicalTrials.gov/show/NCT02913443 Completed Hoffmann-La Roche 2017-10-24
NCT02906384 Memory and MRI Changes With Hippocampus Avoidance Prophylactic Cranial Irradiation(HA-PCI) for Small Cell Lung Cancer(SCLC) https://ClinicalTrials.gov/show/NCT02906384 Recruiting Zhejiang Cancer Hospital 2018-10-31
NCT02893917 Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT02893917 Active, not recruiting National Cancer Institute (NCI) 2020-12-31
NCT02881125 Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma https://ClinicalTrials.gov/show/NCT02881125 Completed University of Washington 2018-01-01
NCT02874664 A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02874664 Completed Stemcentrx 2018-09-12
NCT02815592 Trial of BMS-986012 in Combination With Platinum and Etoposide https://ClinicalTrials.gov/show/NCT02815592 Active, not recruiting Bristol-Myers Squibb 2020-11-30
NCT02769832 Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer https://ClinicalTrials.gov/show/NCT02769832 Recruiting University of Iowa 2023-04-30
NCT02735980 A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02735980 Completed Eli Lilly and Company 2017-07-31
NCT02722369 STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT02722369 Recruiting University College, London 2021-07-31
NCT02721732 Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic https://ClinicalTrials.gov/show/NCT02721732 Recruiting M.D. Anderson Cancer Center 2020-08-20
NCT02701400 Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02701400 Active, not recruiting Emory University 2020-10-31
NCT02675088 Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02675088 Recruiting Chinese Academy of Medical Sciences 2019-12-31
NCT02658214 Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02658214 Completed AstraZeneca 2019-11-14
NCT02649673 LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies https://ClinicalTrials.gov/show/NCT02649673 Active, not recruiting SCRI Development Innovations, LLC 2020-07-27
NCT02605811 Temozolomide in Preventing Brain Metastases in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02605811 Recruiting Guangzhou Medical University 2019-12-31
NCT02589522 Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT02589522 Recruiting National Cancer Institute (NCI) 2020-12-30
NCT02580994 Pembrolizumab in Untreated Extensive SCLC https://ClinicalTrials.gov/show/NCT02580994 Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC 2020-08-31
NCT02573506 Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02573506 Completed Sun Yat-sen University 2020-03-31
NCT04422210 A Study Evaluating The Safety, Tolerability, Pharmacokinetics, And Efficacy Of Venetoclax In Combination With Atezolizumab, Carboplatin, And Etoposide In Participants With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). https://ClinicalTrials.gov/show/NCT04422210 Recruiting Hoffmann-La Roche 2024-07-06
NCT02769962 Trial of CRLX101, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02769962 Recruiting National Institutes of Health Clinical Center (CC) 2023-07-01
NCT02763579 A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT02763579 Active, not recruiting Hoffmann-La Roche 2018-04-24
NCT02674568 Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02674568 Completed AbbVie 2018-10-19
NCT02041845 Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02041845 Active, not recruiting Norwegian University of Science and Technology 2020-06-30
NCT01450761 Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone https://ClinicalTrials.gov/show/NCT01450761 Completed Bristol-Myers Squibb 2015-03-19
NCT02566993 Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02566993 Completed PharmaMar 2020-02-29
NCT03392064 A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC https://ClinicalTrials.gov/show/NCT03392064 Active, not recruiting Amgen 2025-01-13
NCT02551432 Pembrolizumab and Paclitaxel in Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02551432 Completed Seoul National University Hospital 2017-12-31
NCT02538666 An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy https://ClinicalTrials.gov/show/NCT02538666 Active, not recruiting Bristol-Myers Squibb 2018-10-01
NCT02514447 Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy https://ClinicalTrials.gov/show/NCT02514447 Active, not recruiting G1 Therapeutics, Inc. 2018-09-28
NCT03387332 APG-1252 in Patients With SCLC or Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03387332 Recruiting Ascentage Pharma Group Inc. 2019-12-28
NCT02511795 AZD1775 Combined With Olaparib in Patients With Refractory Solid Tumors https://ClinicalTrials.gov/show/NCT02511795 Completed AstraZeneca 2019-04-25
NCT02499770 Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT02499770 Completed G1 Therapeutics, Inc. 2017-07-03
NCT02498613 A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT02498613 Recruiting National Cancer Institute (NCI) 2020-12-31
NCT02496208 Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors https://ClinicalTrials.gov/show/NCT02496208 Recruiting National Cancer Institute (NCI) 2020-09-30
NCT02489903 RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) https://ClinicalTrials.gov/show/NCT02489903 Active, not recruiting EpicentRx, Inc. 2020-12-31
NCT02446704 Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy https://ClinicalTrials.gov/show/NCT02446704 Recruiting Massachusetts General Hospital 2020-08-31
NCT02402920 Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02402920 Recruiting M.D. Anderson Cancer Center 2023-07-31
NCT02397733 Memory Preservation of Prophylactic Cranial Irradiation With Hippocampal Avoidance (PREMER-TRIAL) https://ClinicalTrials.gov/show/NCT02397733 Completed Grupo de Investigación Clínica en Oncología Radioterapia 2019-12-31
NCT02391480 A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer https://ClinicalTrials.gov/show/NCT02391480 Completed AbbVie 2019-07-05
NCT02352948 A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02352948 Active, not recruiting AstraZeneca 2018-02-09
NCT02349412 Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers https://ClinicalTrials.gov/show/NCT02349412 Completed Alliance for Clinical Trials in Oncology 2017-07-03
NCT02337712 Once-daily Simultaneous Modulated Accelerated Thoracic Radiotherapy in Limited Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT02337712 Recruiting Sun Yat-sen University 2020-12-31
NCT02323737 Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02323737 Completed Chinese Academy of Medical Sciences 2011-06-30
NCT02312622 Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer https://ClinicalTrials.gov/show/NCT02312622 Completed Stanford University 2018-09-08
NCT02289690 Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02289690 Completed AbbVie 2019-04-17
NCT02247349 BMS-986012 in Relapsed/Refractory SCLC https://ClinicalTrials.gov/show/NCT02247349 Active, not recruiting Bristol-Myers Squibb 2020-09-28
NCT02223052 Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies https://ClinicalTrials.gov/show/NCT02223052 Completed Celgene 2018-06-11
NCT02200081 Randomized Study of Maintenance Therapy With MGN1703 in Patients With SCLC https://ClinicalTrials.gov/show/NCT02200081 Completed Mologen AG 2016-11-30
NCT02194049 Cisplatin, Etoposide and PI3K Inhibitor BKM120 in Treating Patients With Advanced Solid Tumors or Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02194049 Completed University of California, Davis 2016-04-30
NCT02171325 Study of Different Doses of Irinotecan and Cisplatin for First-line Extensive-stage Small-cell Lung Cancer Treatment https://ClinicalTrials.gov/show/NCT02171325 Recruiting Guangdong Association of Clinical Trials 2020-06-30
NCT02164461 ADXS11-001 High Dose HPV+ Cervical Cancer https://ClinicalTrials.gov/show/NCT02164461 Completed Advaxis, Inc. 2017-04-30
NCT02069158 Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor https://ClinicalTrials.gov/show/NCT02069158 Completed Oncology Institute of Southern Switzerland 2019-05-31
NCT02058056 Early Hippocampal Avoidance Prophylactic Cranial Irradiation in Patients With LD SCLC https://ClinicalTrials.gov/show/NCT02058056 Completed Swiss Group for Clinical Cancer Research 2018-06-07
NCT01306045 Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies https://ClinicalTrials.gov/show/NCT01306045 Active, not recruiting National Institutes of Health Clinical Center (CC) 2020-12-31
NCT02046733 Small Cell Lung Carcinoma Trial With Nivolumab and IpiliMUmab in LImited Disease https://ClinicalTrials.gov/show/NCT02046733 Active, not recruiting European Thoracic Oncology Platform 2020-12-31
NCT02038647 Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT02038647 Completed Takeda 2016-01-03
NCT01999881 Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients https://ClinicalTrials.gov/show/NCT01999881 Completed University of Wisconsin, Madison 2015-07-31
NCT01987232 Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT01987232 Completed Amgen 2016-08-31
NCT01935336 Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers https://ClinicalTrials.gov/show/NCT01935336 Active, not recruiting University of Colorado, Denver 2017-01-31
NCT01931787 CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01931787 Completed Wake Forest University Health Sciences 2015-12-31
NCT01901653 Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01901653 Completed Stemcentrx 2016-11-28
NCT01881906 Exercise in Advanced Stage Lung Cancer Patients https://ClinicalTrials.gov/show/NCT01881906 Completed Rigshospitalet, Denmark 2017-04-12
NCT01880528 Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer https://ClinicalTrials.gov/show/NCT01880528 Completed Mayo Clinic 2013-06-05
NCT01876446 Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01876446 Completed Roswell Park Cancer Institute 2017-07-18
NCT01840579 Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) https://ClinicalTrials.gov/show/NCT01840579 Completed Merck Sharp & Dohme Corp. 2020-02-25
NCT01831089 Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT01831089 Completed PharmaMar 2016-07-31
NCT01797874 Pazopanib Maintenance for SCLC https://ClinicalTrials.gov/show/NCT01797874 Completed Samsung Medical Center 2017-02-28
NCT01797159 Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01797159 Active, not recruiting Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2020-04-30
NCT01780675 Hippocampus Avoidance PCI vs PCI https://ClinicalTrials.gov/show/NCT01780675 Active, not recruiting The Netherlands Cancer Institute 2019-04-01
NCT01737502 Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01737502 Recruiting Mayo Clinic 2020-08-21
NCT01713296 Pazopanib in Relapsed and Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01713296 Completed Hellenic Oncology Research Group 2015-03-31
NCT01642251 Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01642251 Completed National Cancer Institute (NCI) 2016-12-08
NCT01638546 Temozolomide With or Without Veliparib in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01638546 Completed National Cancer Institute (NCI) 2017-01-31
NCT01631552 Phase I/II Study of IMMU-132 in Patients With Epithelial Cancers https://ClinicalTrials.gov/show/NCT01631552 Active, not recruiting Immunomedics, Inc. 2020-06-30
NCT01579929 Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) https://ClinicalTrials.gov/show/NCT01579929 Completed Memorial Sloan Kettering Cancer Center 2017-08-11
NCT01553916 Neuroprotective Effects of Lithium in Patients With Small Cell Lung Cancer Undergoing Radiation Therapy to the Brain https://ClinicalTrials.gov/show/NCT01553916 Completed Washington University School of Medicine 2016-09-12
NCT01533181 Linsitinib or Topotecan Hydrochloride in Treating Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01533181 Completed National Cancer Institute (NCI) 2014-11-30
NCT01505868 Cabazitaxel With or Without Carboplatin in Treating Patients With Previously Treated Metastatic Castration-Resistant Prostate Cancer https://ClinicalTrials.gov/show/NCT01505868 Active, not recruiting M.D. Anderson Cancer Center 2029-07-11
NCT01500720 Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01500720 Completed Sanofi 2014-04-30
NCT01497873 A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01497873 Completed Chong Kun Dang Pharmaceutical 2017-12-31
NCT03348670 Discovery Stage IND EXEMPT Clinical Study - Etoposide OS Plus Methotrexate OS and Single Nucleotide Polymorphisms https://ClinicalTrials.gov/show/NCT03348670 Active, not recruiting Medicine Invention Design, Inc 2020-04-08
NCT01470248 Study of Arsenic Trioxide in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01470248 Completed Emory University 2016-01-31
NCT01457469 Enhanced Quitline Intervention in Smoking Cessation for Patients With Non-Metastatic Lung Cancer https://ClinicalTrials.gov/show/NCT01457469 Completed Wake Forest University Health Sciences 2012-01-31
NCT01441349 Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01441349 Recruiting National Cancer Center, Korea 2019-12-31
NCT01441297 BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01441297 Completed National Cancer Center, Korea 2015-10-31
NCT01439568 A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma https://ClinicalTrials.gov/show/NCT01439568 Completed Eli Lilly and Company 2014-01-31
NCT01401907 Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies https://ClinicalTrials.gov/show/NCT01401907 Active, not recruiting Massachusetts General Hospital 2016-04-30
NCT01357395 A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01357395 Completed Astex Pharmaceuticals, Inc. 2012-05-31
NCT01331525 The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01331525 Completed University Hospital Southampton NHS Foundation Trust 2015-06-30
NCT04400188 A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04400188 Recruiting Jiangsu HengRui Medicine Co., Ltd. 2021-06-29
NCT04381910 Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04381910 Recruiting Luye Pharma Group Ltd. 2022-06-30
NCT04361825 Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects https://ClinicalTrials.gov/show/NCT04361825 Enrolling by invitation Samsung Medical Center 2023-05-31
NCT04346914 Study of ZKAB001 Combined With Carboplatin and Etoposide in the Extensive Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04346914 Recruiting Lee’s Pharmaceutical Limited 2020-12-31
NCT04342429 Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04342429 Recruiting Emory University 2024-05-27
NCT04332653 NT-I7 (Hyleukin-7) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04332653 Recruiting NeoImmuneTech 2022-06-30
NCT04256421 A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04256421 Recruiting Hoffmann-La Roche 2023-09-29
NCT04254471 This Phase II/III, Multicenter Study is Designed to Evaluate the Safety and Clinical Activity of AL3810 in Patients https://ClinicalTrials.gov/show/NCT04254471 Recruiting ShangHai HaiHe Pharmaceutical 2022-05-22
NCT04253145 Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. https://ClinicalTrials.gov/show/NCT04253145 Recruiting Fundacion Oncosur 2020-12-31
NCT04234113 Study of SO-C101 and SO-C101in Combination With Pembro in Adult Patients With Advanced/Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT04234113 Recruiting Sotio a.s. 2022-03-31
NCT04229381 Resiliency Among Older Adults Receiving Lung Cancer Treatment https://ClinicalTrials.gov/show/NCT04229381 Recruiting Ohio State University Comprehensive Cancer Center 2021-12-31
NCT04209595 PLX038 (PEGylated SN38) and Rucaparib in Solid Tumors and Small Cell Cancers https://ClinicalTrials.gov/show/NCT04209595 Recruiting National Institutes of Health Clinical Center (CC) 2022-12-31
NCT04192682 Anlotinib Combined With Sintilimab as Second-line Treatment or Beyond in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04192682 Recruiting Changzhou Cancer Hospital of Soochow University 2021-03-01
NCT04187872 LITT and Pembrolizumab in Recurrent Brain Metastasis https://ClinicalTrials.gov/show/NCT04187872 Recruiting University of Florida 2022-01-31
NCT04180176 Prospective Clinicogenomic Program https://ClinicalTrials.gov/show/NCT04180176 Recruiting Genentech, Inc. 2025-03-01
NCT04173325 Feasibility and Safety Study of Nivolumab With Irinotecan for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04173325 Recruiting Augusta University 2021-11-30
NCT04171986 Mecapegfilgrastim Prevents Neutropenia and Radiation Esophagitis https://ClinicalTrials.gov/show/NCT04171986 Recruiting Tianjin Medical University Cancer Institute and Hospital 2021-10-31
NCT04168281 Watchful Observation of Patients With LD-SCLC Instead of the PCI https://ClinicalTrials.gov/show/NCT04168281 Recruiting University of Warmia and Mazury in Olsztyn 2023-12-31
NCT04165330 Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors https://ClinicalTrials.gov/show/NCT04165330 Recruiting Sarcoma Oncology Research Center, LLC 2021-12-31
NCT04158336 A Study of ZN-c3 in Participants With Solid Tumors https://ClinicalTrials.gov/show/NCT04158336 Recruiting K-Group Beta 2023-05-31
NCT04155034 Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04155034 Recruiting Southwest Oncology Group 2025-11-15
NCT04128800 Appatinib Combined With S-1 in the Treatment of Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04128800 Recruiting Tianjin Medical University Cancer Institute and Hospital 2020-12-31
NCT04116320 Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT04116320 Recruiting University of Virginia 2022-11-30
NCT04063163 A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) https://ClinicalTrials.gov/show/NCT04063163 Recruiting Shanghai Henlius Biotech 2021-09-17
NCT04056949 Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy https://ClinicalTrials.gov/show/NCT04056949 Recruiting Peking Union Medical College 2021-02-01
NCT04055792 Sintilimab Combined With Anlotinib in Third Line or Beyond Among Advanced SCLC Patients https://ClinicalTrials.gov/show/NCT04055792 Recruiting Henan Cancer Hospital 2021-03-01
NCT04028050 A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04028050 Recruiting Hoffmann-La Roche 2022-12-30
NCT04022876 A Study of ALRN-6924 for the Prevention of Topotecan-induced Myelosuppression During Treatment for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04022876 Recruiting Aileron Therapeutics 2021-03-31
NCT04012606 Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04012606 Recruiting Shanghai Junshi Bioscience Co., Ltd. 2021-07-06
NCT04010357 Targeted Therapy With CDK4/6 Inhibitors in Chemo-Refractory, Rb Wild-Type Extensive SCLC https://ClinicalTrials.gov/show/NCT04010357 Recruiting Case Comprehensive Cancer Center 2021-12-31
NCT03995667 Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03995667 Recruiting OHSU Knight Cancer Institute 2021-06-20
NCT03994744 Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC https://ClinicalTrials.gov/show/NCT03994744 Recruiting Hunan Cancer Hospital 2021-08-01
NCT03983759 Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03983759 Recruiting Henan Cancer Hospital 2021-05-31
NCT03958045 Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma https://ClinicalTrials.gov/show/NCT03958045 Recruiting University of Kentucky 2023-07-31
NCT03913455 Guadecitabine in Combination With Carboplatin in Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03913455 Recruiting Hoosier Cancer Research Network 2020-06-30
NCT03910660 A Trial of BXCL701 and Pembrolizumab in Patients With Small Cell Neuroendocrine Prostate Cancer https://ClinicalTrials.gov/show/NCT03910660 Recruiting BioXcel Therapeutics Inc 2022-04-02
NCT03898791 A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03898791 Active, not recruiting Eli Lilly and Company 2020-06-02
NCT03896503 Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs https://ClinicalTrials.gov/show/NCT03896503 Recruiting National Cancer Institute (NCI) 2023-09-01
NCT03879798 DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03879798 Recruiting Memorial Sloan Kettering Cancer Center 2022-03-31
NCT03849469 A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03849469 Recruiting Xencor, Inc. 2026-09-30
NCT03841136 Anlotinib Combined With Etoposide and Platinum in the Treatment of Lung Cancer https://ClinicalTrials.gov/show/NCT03841136 Recruiting Fudan University 2019-12-01
NCT03841110 FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03841110 Recruiting Fate Therapeutics 2022-03-31
NCT03830918 Niraparib and Temozolomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy https://ClinicalTrials.gov/show/NCT03830918 Recruiting Jonsson Comprehensive Cancer Center 2021-01-03
NCT03811379 Toripalimab as Monotherapy for Patients With Small Cell Carcinoma of Esophagus Who Failed Chemotherapy https://ClinicalTrials.gov/show/NCT03811379 Recruiting Sun Yat-sen University 2020-12-30
NCT03776604 PEG-rhG-CSF in Elderly Patients With Small Cell Lung Cancer Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT03776604 Recruiting CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. 2019-12-31
NCT03769935 Maintenance Therapy for Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT03769935 Recruiting Qingdao Central Hospital 2020-01-01
NCT03761914 Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers https://ClinicalTrials.gov/show/NCT03761914 Recruiting Sellas Life Sciences Group 2020-12-31
NCT03752398 A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) https://ClinicalTrials.gov/show/NCT03752398 Recruiting Xencor, Inc. 2024-09-30
NCT03735095 Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer https://ClinicalTrials.gov/show/NCT03735095 Recruiting Roswell Park Cancer Institute 2020-10-01
NCT03732846 Anlotinib in Treatment of Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03732846 Recruiting Beijing Cancer Hospital 2020-05-01
NCT03728361 Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer https://ClinicalTrials.gov/show/NCT03728361 Recruiting Ohio State University Comprehensive Cancer Center 2021-12-31
NCT03703297 Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy https://ClinicalTrials.gov/show/NCT03703297 Recruiting AstraZeneca 2024-02-19
NCT03700359 A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC https://ClinicalTrials.gov/show/NCT03700359 Recruiting The First Affiliated Hospital of Guangzhou Medical University 2020-11-29
NCT03672773 Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03672773 Recruiting Jonsson Comprehensive Cancer Center 2020-11-01
NCT03662074 Subsequent Line Gemcitabine and Nivolumab in Treating Participants With Metastatic Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03662074 Recruiting Wake Forest University Health Sciences 2020-09-10
NCT03661567 Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03661567 Recruiting Sun Yat-sen University 2021-09-30
NCT03659578 Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03659578 Recruiting Sun Yat-sen University 2020-09-30
NCT03652077 A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies https://ClinicalTrials.gov/show/NCT03652077 Recruiting Incyte Corporation 2021-01-31
NCT03639194 A Study of ABBV-011 Alone and in Combination With ABBV-181 in Subjects With Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03639194 Recruiting AbbVie 2023-09-26
NCT03613753 Irinotecan Plus Lobaplatin Versus Irinotecan in the Second-line Treatment of Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03613753 Recruiting Guizhou Medical University 2020-06-01
NCT03613597 Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT03613597 Recruiting Guizhou Medical University 2021-01-01
NCT03585998 Chemoradiation With Durvalumab Followed by Durvalumab Maintenance for Limited Disease Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03585998 Active, not recruiting Samsung Medical Center 2021-06-19
NCT03583086 Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors https://ClinicalTrials.gov/show/NCT03583086 Recruiting Vanderbilt-Ingram Cancer Center 2023-07-31
NCT03582475 Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate https://ClinicalTrials.gov/show/NCT03582475 Recruiting Jonsson Comprehensive Cancer Center 2020-09-01
NCT03575793 A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03575793 Recruiting Big Ten Cancer Research Consortium 2021-09-30
NCT03568097 Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT03568097 Recruiting Hellenic Cooperative Oncology Group 2020-11-30
NCT03554473 M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers https://ClinicalTrials.gov/show/NCT03554473 Recruiting National Institutes of Health Clinical Center (CC) 2023-01-15
NCT03547804 A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03547804 Recruiting First Hospital of Jilin University 2020-08-01
NCT03540420 Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT03540420 Recruiting Norwegian University of Science and Technology 2023-12-31
NCT03538028 A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies https://ClinicalTrials.gov/show/NCT03538028 Recruiting Incyte Corporation 2020-09-24
NCT03532880 A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03532880 Recruiting Memorial Sloan Kettering Cancer Center 2021-06-30
NCT03523234 Neoadjuvant Therapy Combined With Radical Surgery for the Treatment of Small Cell Lung Cancer (SCLC) in II and IIIA Stage https://ClinicalTrials.gov/show/NCT03523234 Recruiting Shanghai Pulmonary Hospital, Shanghai, China 2023-07-31
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03517488 Recruiting Xencor, Inc. 2020-12-31
NCT03516084 A Study of Niraparib as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03516084 Recruiting Zai Lab (Shanghai) Co., Ltd. 2019-10-31
NCT03514849 Clinical Study of Combined Radical Operation With Postoperative Adjuvant Chemotherapy and Prophylactic Cranial Irradiation in pT1-2N0M0 Stage of Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03514849 Recruiting Shanghai Pulmonary Hospital, Shanghai, China 2021-03-31
NCT03509012 Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03509012 Active, not recruiting AstraZeneca 2022-04-04
NCT03488472 Radiosurgery Plus NovoTTF-200A for Metastatic Small Cell Lung Cancer to the Brain https://ClinicalTrials.gov/show/NCT03488472 Recruiting University of Alabama at Birmingham 2022-04-30
NCT03467360 Inhibition of CArbonic Anhydrase in Combination With Platinum and Etoposide-based Radiochemotherapy in Patients With Localized Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03467360 Recruiting Centre Antoine Lacassagne 2021-11-30
NCT03449901 ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing’s Sarcoma, and Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03449901 Recruiting Washington University School of Medicine 2021-05-09
NCT03428607 Study of AZD6738 and Olaparib Combination Therapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N2] https://ClinicalTrials.gov/show/NCT03428607 Active, not recruiting Samsung Medical Center 2020-06-30
NCT01266447 Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer https://ClinicalTrials.gov/show/NCT01266447 Completed National Cancer Institute (NCI) 2016-01-31
NCT01253369 Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01253369 Completed Dana-Farber Cancer Institute 2012-09-30
NCT01222936 LBH Phase II in Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT01222936 Completed Southern Europe New Drug Organization 2009-06-30
NCT01221675 TF2- Small Cell Lung Cancer Radio Immunotherapy https://ClinicalTrials.gov/show/NCT01221675 Completed Centre René Gauducheau 2016-04-30
NCT01173523 Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01173523 Completed Dana-Farber Cancer Institute 2013-06-07
NCT01166191 Concurrent Chemo-radiotherapy With Intensity-Modulated Radiation Therapy (IMRT) for Limited Disease Small Cell Lung Cancer (LD-SCLC) https://ClinicalTrials.gov/show/NCT01166191 Completed Maastricht Radiation Oncology 2017-05-31
NCT01155258 Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT01155258 Completed University of Southern California 2013-01-31
NCT01125995 Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT01125995 Completed Samsung Medical Center 2011-07-31
NCT01079481 Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01079481 Completed Samsung Medical Center 2012-05-31
NCT01076504 A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01076504 Completed SCRI Development Innovations, LLC 2012-03-31
NCT01069653 Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01069653 Completed Shiga University 2019-03-31
NCT01064466 Discovery Stage IND EXEMPT SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms https://ClinicalTrials.gov/show/NCT01064466 Active, not recruiting Medicine Invention Design, Inc 2020-03-31
NCT01057342 Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01057342 Completed Swiss Group for Clinical Cancer Research 2011-05-31
NCT01055197 Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01055197 Completed Radiation Therapy Oncology Group 2015-03-31
NCT01045421 Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies https://ClinicalTrials.gov/show/NCT01045421 Completed Millennium Pharmaceuticals, Inc. 2013-05-31
NCT01025284 A Study for Participants With Small-Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01025284 Completed Eli Lilly and Company 2012-07-31
NCT00984542 Bendamustine as Second-Line Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00984542 Completed Vanderbilt-Ingram Cancer Center 2012-09-30
NCT00951613 A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00951613 Completed Nippon Kayaku Co., Ltd. 2012-01-31
NCT00930891 Bevacizumab in Extensive Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00930891 Completed Intergroupe Francophone de Cancerologie Thoracique 2012-07-31
NCT00927875 A Study of BMS-833923 With Carboplatin and Etoposide Followed by BMS-833923 Alone in Subjects With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00927875 Completed Bristol-Myers Squibb 2012-09-30
NCT00926640 A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers https://ClinicalTrials.gov/show/NCT00926640 Completed National Institutes of Health Clinical Center (CC) 2017-06-16
NCT00921739 Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies https://ClinicalTrials.gov/show/NCT00921739 Completed Duke University 2014-12-31
NCT00912392 Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) https://ClinicalTrials.gov/show/NCT00912392 Completed Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd 2012-12-31
NCT00907569 Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00907569 Completed AHS Cancer Control Alberta 2011-04-30
NCT00887159 A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage https://ClinicalTrials.gov/show/NCT00887159 Completed National Cancer Institute (NCI) 2016-11-15
NCT00869752 MK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00869752 Completed Canadian Cancer Trials Group 2012-03-15
NCT00856830 Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00856830 Completed University of Alabama at Birmingham 2015-05-31
NCT00856037 Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00856037 Completed University of Nebraska 2018-02-01
NCT04210037 Study of Combination APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04210037 Recruiting Ascentage Pharma Group Inc. 2021-06-01
NCT00828139 S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00828139 Completed National Cancer Institute (NCI) 2012-09-30
NCT03850067 A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Etoposide in Subjects With First Line, Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03850067 Recruiting Celgene 2021-09-30
NCT03734913 A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT03734913 Recruiting Guangdong Zhongsheng Pharmaceutical Co., Ltd. 2020-11-01
NCT03253068 Pembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT03253068 Active, not recruiting Wakayama Medical University 2020-12-28
NCT01970540 Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors https://ClinicalTrials.gov/show/NCT01970540 Completed PharmaMar 2017-08-09
NCT03708328 A Dose Escalation and Expansion Study of RO7121661, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT03708328 Recruiting Hoffmann-La Roche 2023-05-31
NCT03460977 PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma https://ClinicalTrials.gov/show/NCT03460977 Recruiting Pfizer 2023-03-31
NCT02481830 Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer https://ClinicalTrials.gov/show/NCT02481830 Active, not recruiting Bristol-Myers Squibb 2018-08-17
NCT04213937 Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04213937 Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2021-07-31
NCT04005716 Study of Platinum Plus Etoposide With or Without BGB-A317 in Participants With Untreated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04005716 Recruiting BeiGene 2021-07-31
NCT03811652 A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors https://ClinicalTrials.gov/show/NCT03811652 Completed MedImmune LLC 2019-12-10
NCT03216343 Phase Ib Study of Chiauranib in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03216343 Recruiting Chipscreen Biosciences, Ltd. 2020-08-30
NCT02635009 Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Treating Patients With Limited Stage or Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT02635009 Recruiting NRG Oncology 2022-04-30
NCT04079712 Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors https://ClinicalTrials.gov/show/NCT04079712 Recruiting National Cancer Institute (NCI) 2021-10-01
NCT03866382 Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors https://ClinicalTrials.gov/show/NCT03866382 Recruiting National Cancer Institute (NCI) 2023-02-28
NCT02487095 Trial of Topotecan With VX-970 (M6620), an ATR Kinase Inhibitor, in Small Cell Cancers and Extrapulmonary Small Cell Cancers https://ClinicalTrials.gov/show/NCT02487095 Recruiting National Institutes of Health Clinical Center (CC) 2024-05-31
NCT04453930 A Study of Sequential Therapy of Camrelizumab Combined With Chemotherapy(Irinotecan Plus Platinum)and With Apatinib in Participants With Untreated Advanced Small Cell Lung Cancer(SCLC) https://ClinicalTrials.gov/show/NCT04453930 Recruiting Peking Union Medical College Hospital 2023-06-30
NCT03699956 RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03699956 Active, not recruiting EpicentRx, Inc. 2020-11-01
NCT00791154 QUILT-2.013: A Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00791154 Completed NantCell, Inc. 2012-06-30
NCT00773955 R-(-)-Gossypol Acetic Acid in Treating Patients With Recurrent Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00773955 Completed National Cancer Institute (NCI) 2009-10-31
NCT00759824 A Phase II Study of Doxorubicin, Cyclophosphamide and Vindesine With Valproic Acid in Patients With Refractory or Relapsing Small Cell Lung Cancer After Platinum Derivatives and Etoposide https://ClinicalTrials.gov/show/NCT00759824 Completed European Lung Cancer Working Party 2013-12-31
NCT00756639 Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium https://ClinicalTrials.gov/show/NCT00756639 Active, not recruiting M.D. Anderson Cancer Center 2020-06-30
NCT00754858 Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00754858 Completed Yonsei University 2010-05-31
NCT00744900 Pemetrexed Plus Cisplatin for Brain Metastasis of Advanced Non - Small Cell Lung Cancer (NSCLC) https://ClinicalTrials.gov/show/NCT00744900 Completed University Hospital, Brest NA
NCT00740636 Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00740636 Completed Memorial Sloan Kettering Cancer Center 2013-02-28
NCT00717938 A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00717938 Completed Lund University Hospital 2017-05-31
NCT00698516 Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00698516 Completed GlaxoSmithKline 2010-05-31
NCT00695292 Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00695292 Completed SCRI Development Innovations, LLC 2011-06-30
NCT00682981 A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) https://ClinicalTrials.gov/show/NCT00682981 Completed Teva Pharmaceutical Industries 2011-11-30
NCT00658580 Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00658580 Completed European Lung Cancer Working Party 2013-12-31
NCT00643396 Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00643396 Completed AHS Cancer Control Alberta 2012-01-31
NCT00632853 Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide https://ClinicalTrials.gov/show/NCT00632853 Active, not recruiting Alliance for Clinical Trials in Oncology 2023-06-30
NCT00620347 Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00620347 Completed National Cancer Center, Korea 2012-02-29
NCT00617409 To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid https://ClinicalTrials.gov/show/NCT00617409 Completed H. Lee Moffitt Cancer Center and Research Institute 2015-09-21
NCT00616109 Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC https://ClinicalTrials.gov/show/NCT00616109 Completed University of Michigan Rogel Cancer Center 2009-12-31
NCT00613626 Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00613626 Completed Hoosier Cancer Research Network 2015-08-31
NCT01286987 Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors https://ClinicalTrials.gov/show/NCT01286987 Completed Pfizer 2015-03-31
NCT00580320 Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma https://ClinicalTrials.gov/show/NCT00580320 Completed Virginia Commonwealth University 2009-10-31
NCT00554463 G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00554463 Completed Radiation Therapy Oncology Group 2011-08-31
NCT00547651 AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy https://ClinicalTrials.gov/show/NCT00547651 Completed Celgene 2011-05-01
NCT00544596 R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00544596 Completed National Cancer Institute (NCI) 2013-07-31
NCT00531284 Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma https://ClinicalTrials.gov/show/NCT00531284 Completed Amgen 2014-10-31
NCT00528645 AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00528645 Completed National Cancer Institute (NCI) 2008-11-30
NCT00527735 Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT00527735 Completed Bristol-Myers Squibb 2009-10-31
NCT00521144 Obatoclax Mesylate and Topotecan Hydrochloride in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer or Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00521144 Completed National Cancer Institute (NCI) 2010-08-31
NCT00483509 Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma https://ClinicalTrials.gov/show/NCT00483509 Completed MolMed S.p.A. 2010-09-22
NCT00470054 Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00470054 Completed National Cancer Institute (NCI) 2009-02-28
NCT00469898 Irinotecan and Carboplatin as First-Line Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00469898 Completed Vanderbilt-Ingram Cancer Center 2008-07-31
NCT00469222 Hypofractionated Radiotherapy for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00469222 Completed AHS Cancer Control Alberta 2011-04-30
NCT00466466 Safety of RAD001 in Combination With Cisplatin and Etoposide in Lung Cancer Patients https://ClinicalTrials.gov/show/NCT00466466 Completed Novartis 2010-11-30
NCT00466232 Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00466232 Completed HealthPartners Institute 2009-12-31
NCT00455052 A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00455052 Completed Mersana Therapeutics 2011-12-31
NCT00453167 Weekly Paclitaxel Plus Gemcitabine as Second-line in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00453167 Completed National Cancer Center, Korea 2009-12-31
NCT00453154 Cisplatin or Carboplatin, and Etoposide With or Without Sunitinib Malate in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00453154 Completed National Cancer Institute (NCI) 2013-06-30
NCT00452634 Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) https://ClinicalTrials.gov/show/NCT00452634 Completed National Cancer Center, Korea 2009-11-30
NCT00445198 A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies https://ClinicalTrials.gov/show/NCT00445198 Completed AbbVie 2010-12-31
NCT00020202 FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00020202 Completed National Cancer Institute (NCI) NA
NCT00019006 Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer https://ClinicalTrials.gov/show/NCT00019006 Completed National Cancer Institute (NCI) NA
NCT00433563 Concurrent Once Daily Versus Twice Daily Radiotherapy for Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00433563 Completed The Christie NHS Foundation Trust 2016-02-29
NCT00433498 Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00433498 Completed University College, London 2012-01-31
NCT00423254 Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. https://ClinicalTrials.gov/show/NCT00423254 Completed Mannkind Corporation 2009-09-30
NCT00416455 Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer https://ClinicalTrials.gov/show/NCT00416455 Completed National Cancer Institute (NCI) 2014-09-30
NCT00415363 Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy https://ClinicalTrials.gov/show/NCT00415363 Completed Eli Lilly and Company 2011-01-31
NCT00403403 A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) https://ClinicalTrials.gov/show/NCT00403403 Completed Genentech, Inc. 2009-02-28
NCT00401609 G-Step: Gemcitabine Based Small-cell Lung Cancer Treatment in Elderly Patients https://ClinicalTrials.gov/show/NCT00401609 Completed National Cancer Institute, Naples 2007-12-31
NCT00397293 Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00397293 Completed Ascenta Therapeutics 2008-12-31
NCT00388960 Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00388960 Completed Celgene 2010-04-01
NCT00387699 Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00387699 Completed National Cancer Institute (NCI) 2007-10-31
NCT00387660 Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00387660 Completed University of California, Davis 2008-08-31
NCT00375193 Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy https://ClinicalTrials.gov/show/NCT00375193 Completed Celgene 2008-05-01
NCT00374140 Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00374140 Completed University of Pittsburgh 2008-12-31
NCT00363415 Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00363415 Completed Eli Lilly and Company 2008-06-30
NCT00359359 A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00359359 Completed Bayer 2009-03-31
NCT00349492 A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer https://ClinicalTrials.gov/show/NCT00349492 Completed Clinical Research Center for Solid Tumor, Korea 2011-12-31
NCT00320359 Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00320359 Completed GlaxoSmithKline 2007-02-28
NCT00319969 Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. https://ClinicalTrials.gov/show/NCT00319969 Completed Celgene 2008-07-31
NCT00317200 A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00317200 Completed Hoosier Cancer Research Network 2007-11-30
NCT00316186 First-line Treatment Of Subjects With Extensive Disease Small Cell Lung Cancer With Weekly Hycamtin And Paraplatin https://ClinicalTrials.gov/show/NCT00316186 Completed GlaxoSmithKline 2009-03-31
NCT00309959 ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer https://ClinicalTrials.gov/show/NCT00309959 Completed Gynecologic Oncology Group 2011-02-28
NCT00308529 Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00308529 Completed SCRI Development Innovations, LLC 2007-04-30
NCT00305942 Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00305942 Completed SCRI Development Innovations, LLC 2009-04-30
NCT00298896 Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00298896 Completed Sunesis Pharmaceuticals 2007-08-31
NCT00298688 A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00298688 Completed AstraZeneca NA
NCT00294931 Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00294931 Completed SCRI Development Innovations, LLC 2007-05-31
NCT00294190 Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00294190 Completed SCRI Development Innovations, LLC 2007-09-30
NCT00290953 Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide https://ClinicalTrials.gov/show/NCT00290953 Completed Sanofi 2006-03-31
NCT00284154 Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00284154 Completed SCRI Development Innovations, LLC 2009-05-31
NCT00282022 VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00282022 Completed National Cancer Institute (NCI) 2008-05-31
NCT00276276 Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00276276 Completed GlaxoSmithKline NA
NCT00270166 The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy https://ClinicalTrials.gov/show/NCT00270166 Completed Johnson & Johnson Pharmaceutical Research & Development, L.L.C. NA
NCT00259935 A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00259935 Completed GlaxoSmithKline 2007-07-05
NCT00252889 Doxil Topotecan Doublet Cancer Study https://ClinicalTrials.gov/show/NCT00252889 Completed Christiana Care Health Services 2006-03-31
NCT00248482 Imatinib Mesylate After Irinotecan and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00248482 Completed Barbara Ann Karmanos Cancer Institute 2005-04-30
NCT00245063 AZD2171 in Treating Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00245063 Completed National Cancer Institute (NCI) 2010-03-31
NCT00227565 Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00227565 Completed Alliance for Clinical Trials in Oncology 2007-12-31
NCT00217633 Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer https://ClinicalTrials.gov/show/NCT00217633 Completed Gynecologic Oncology Group 2013-01-31
NCT00213798 Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients https://ClinicalTrials.gov/show/NCT00213798 Completed University Hospital, Strasbourg, France NA
NCT00193401 Weekly Topotecan in the First-line Treatment of Elderly Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00193401 Completed SCRI Development Innovations, LLC 2004-06-30
NCT00193388 Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00193388 Completed SCRI Development Innovations, LLC 2004-12-31
NCT00193375 Irinotecan, Carboplatin and Radiation Therapy Followed by Bevacizumab in Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00193375 Completed SCRI Development Innovations, LLC 2008-04-30
NCT00191750 A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned https://ClinicalTrials.gov/show/NCT00191750 Completed Eli Lilly and Company NA
NCT00182689 Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00182689 Completed National Cancer Institute (NCI) 2008-10-31
NCT00156286 Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC https://ClinicalTrials.gov/show/NCT00156286 Completed University of Michigan Rogel Cancer Center 2006-01-31
NCT00144989 A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC https://ClinicalTrials.gov/show/NCT00144989 Completed Japan Clinical Oncology Group 2011-09-30
NCT00143455 Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00143455 Completed Pfizer 2008-12-31
NCT00132054 Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00132054 Completed National Cancer Institute (NCI) 2006-12-31
NCT00126828 Study of Radiation Dose Intensity Concurrent With Chemotherapy For Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00126828 Completed AHS Cancer Control Alberta 2007-09-30
NCT00119613 A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa https://ClinicalTrials.gov/show/NCT00119613 Completed Amgen 2007-01-31
NCT00118235 Cisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00118235 Completed National Cancer Institute (NCI) 2007-04-30
NCT00116610 Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00116610 Completed Poniard Pharmaceuticals 2007-03-31
NCT00104910 Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer https://ClinicalTrials.gov/show/NCT00104910 Completed Gynecologic Oncology Group 2013-01-31
NCT00104793 Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00104793 Completed National Cancer Institute (NCI) 2007-02-28
NCT00098956 7-hydroxystaurosporine and Topotecan Hydrochloride in Treating Patients With Relapsed or Progressed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00098956 Completed National Cancer Institute (NCI) 2010-06-30
NCT00003279 Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003279 Completed European Organisation for Research and Treatment of Cancer - EORTC 2000-01-31
NCT00004186 Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00004186 Completed University of Alabama at Birmingham 2004-12-31
NCT00003812 Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003812 Completed Alliance for Clinical Trials in Oncology 2004-06-30
NCT00086827 Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00086827 Completed National Cancer Institute (NCI) 2006-11-30
NCT00005041 R115777 in Treating Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00005041 Completed NYU Langone Health 2000-05-31
NCT00084799 Monoclonal Antibody Therapy in Treating Patients With Progressive Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00084799 Completed Ludwig Institute for Cancer Research NA
NCT00005032 Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00005032 Completed University of Chicago 2001-01-31
NCT00004055 Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00004055 Completed Alliance for Clinical Trials in Oncology 2004-07-31
NCT00004176 Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00004176 Completed Washington University School of Medicine 2001-02-28
NCT00083161 Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00083161 Completed Gundersen Lutheran Health System 2010-05-31
NCT00004249 Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy https://ClinicalTrials.gov/show/NCT00004249 Completed Memorial Sloan Kettering Cancer Center 2001-11-30
NCT00003917 Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003917 Completed Case Comprehensive Cancer Center 2001-11-30
NCT00004137 S9914: Combination Chemotherapy Plus Filgrastim in Untreated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00004137 Completed Southwest Oncology Group 2004-03-31
NCT00006487 S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00006487 Completed Southwest Oncology Group 2004-07-31
NCT00005972 Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00005972 Completed Alliance for Clinical Trials in Oncology 2006-10-31
NCT00080015 Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT00080015 Completed Ipsen 2005-02-28
NCT00079040 Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00079040 Completed National Cancer Institute (NCI) 2009-01-31
NCT00003299 Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003299 Completed Alliance for Clinical Trials in Oncology 2005-06-30
NCT00003011 Marimastat Following Chemotherapy in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003011 Completed Canadian Cancer Trials Group 2001-02-13
NCT00005022 Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00005022 Completed Radiation Therapy Oncology Group 2002-10-31
NCT00003364 Radiation Therapy Plus Combination Chemotherapy In Treating Patients With Limited Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003364 Completed National Cancer Institute (NCI) NA
NCT00005646 Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00005646 Completed Alliance for Clinical Trials in Oncology 2004-01-31
NCT00008372 Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00008372 Completed City of Hope Medical Center 2002-09-30
NCT00072527 Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00072527 Completed Alliance for Clinical Trials in Oncology 2007-06-30
NCT00006012 Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00006012 Completed Alliance for Clinical Trials in Oncology 2006-05-31
NCT00003281 Topotecan and Paclitaxel in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00003281 Completed Alliance for Clinical Trials in Oncology 2006-03-31
NCT00068549 Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer https://ClinicalTrials.gov/show/NCT00068549 Completed Gynecologic Oncology Group 2008-01-31
NCT00068289 Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy https://ClinicalTrials.gov/show/NCT00068289 Completed National Cancer Institute (NCI) NA
NCT00066742 Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00066742 Completed National Cancer Institute (NCI) 2009-08-31
NCT00066313 ZD6474 in Treating Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00066313 Completed Sanofi 2006-12-31
NCT00066222 Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00066222 Completed Radiation Therapy Oncology Group 2012-05-31
NCT00006352 Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00006352 Completed European Organisation for Research and Treatment of Cancer - EORTC 2002-10-31
NCT00065429 Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00065429 Completed ImmunoGen, Inc. 2008-11-30
NCT00028925 Combination Chemotherapy With or Without Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00028925 Completed Alliance for Clinical Trials in Oncology 2005-11-30
NCT00062322 Neoadjuvant Chemoradiotherapy Followed By Surgery in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00062322 Completed Fox Chase Cancer Center NA
NCT00062010 Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00062010 Completed Eastern Cooperative Oncology Group 2011-05-31
NCT00061919 Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00061919 Completed University College, London 2007-02-28
NCT00006349 Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00006349 Completed Alliance for Clinical Trials in Oncology 2005-01-31
NCT00006082 Nitrocamptothecin in Treating Patients With Advanced Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00006082 Completed European Organisation for Research and Treatment of Cancer - EORTC 2002-08-31
NCT00059761 Chemotherapy Combined With Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00059761 Completed Radiation Therapy Oncology Group 2009-03-31
NCT00002822 Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00002822 Completed National Cancer Institute (NCI) NA
NCT00057837 Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00057837 Completed Eastern Cooperative Oncology Group 2012-01-31
NCT00057746 Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00057746 Completed Radiation Therapy Oncology Group 2009-05-31
NCT00053300 Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00053300 Completed Case Comprehensive Cancer Center 2005-11-30
NCT00052949 Imatinib Mesylate in Treating Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00052949 Completed National Cancer Institute (NCI) 2007-10-31
NCT00052494 Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00052494 Completed University Health Network, Toronto 2009-02-28
NCT00049218 Chemotherapy Followed By Vaccine Therapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00049218 Completed H. Lee Moffitt Cancer Center and Research Institute 2007-06-30
NCT00045604 Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00045604 Completed National Cancer Institute (NCI) NA
NCT00045162 S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00045162 Completed Southwest Oncology Group 2008-03-31
NCT00042978 Carboplatin and Etoposide With or Without Oblimersen Sodium in Treating Patients With Extensive Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00042978 Completed National Cancer Institute (NCI) 2005-05-31
NCT00041054 Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00041054 Completed Alliance for Clinical Trials in Oncology 2004-08-31
NCT00041015 Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00041015 Completed Case Comprehensive Cancer Center 2002-11-30
NCT00033696 Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00033696 Completed Alliance for Clinical Trials in Oncology 2007-01-31
NCT00031681 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) https://ClinicalTrials.gov/show/NCT00031681 Completed National Cancer Institute (NCI) 2011-01-31
NCT00030433 S0119: Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00030433 Completed Southwest Oncology Group 2007-02-28
NCT00028535 Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors https://ClinicalTrials.gov/show/NCT00028535 Completed National Cancer Institute (NCI) 2009-02-28
NCT00028028 CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00028028 Completed National Cancer Institute (NCI) 2007-01-31
NCT00025272 Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00025272 Completed Wake Forest University Health Sciences 2005-01-18
NCT00022711 Temozolomide in Treating Patients With Relapsed or Progressive Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00022711 Completed Fox Chase Cancer Center 2004-01-31
NCT00017251 Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00017251 Completed National Cancer Institute (NCI) 2004-01-31
NCT00016211 Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00016211 Completed European Organisation for Research and Treatment of Cancer - EORTC 2006-03-31
NCT00009971 Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00009971 Completed National Cancer Institute (NCI) 2005-09-30
NCT00005062 Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission https://ClinicalTrials.gov/show/NCT00005062 Completed Gustave Roussy, Cancer Campus, Grand Paris 2005-12-31
NCT00046111 A Bioequivalence Study of Two Oral Formulations of Topotecan in Patients With Advanced Solid Tumors https://ClinicalTrials.gov/show/NCT00046111 Completed GlaxoSmithKline 2004-04-30
NCT00043927 Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults https://ClinicalTrials.gov/show/NCT00043927 Completed GlaxoSmithKline 2004-01-31
NCT00043862 The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT00043862 Completed GlaxoSmithKline 2005-11-30
NCT00037817 Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies https://ClinicalTrials.gov/show/NCT00037817 Completed National Institutes of Health Clinical Center (CC) 2008-10-08
NCT00037713 Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG https://ClinicalTrials.gov/show/NCT00037713 Completed Eli Lilly and Company 2002-10-31
NCT00046787 Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT00046787 Completed Astellas Pharma Inc NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03782207 A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03782207 Recruiting Hoffmann-La Roche 2024-12-19
NCT03162705 Molecular Profiling in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT03162705 Recruiting Zhujiang Hospital 2021-12-31
NCT03232593 A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) https://ClinicalTrials.gov/show/NCT03232593 Recruiting Hoffmann-La Roche 2023-01-11
NCT02688894 The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S] https://ClinicalTrials.gov/show/NCT02688894 Recruiting Samsung Medical Center 2022-03-31
NCT02146170 Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors https://ClinicalTrials.gov/show/NCT02146170 Recruiting National Institutes of Health Clinical Center (CC) 2024-04-30
NCT02324296 PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases https://ClinicalTrials.gov/show/NCT02324296 Completed Arcispedale Santa Maria Nuova-IRCCS 2009-01-31
NCT02273336 Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer https://ClinicalTrials.gov/show/NCT02273336 Active, not recruiting University of Southern California 2020-07-22
NCT04451460 Effect of Hyponatremia in Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT04451460 Completed Ankara City Hospital Bilkent 2017-01-01
NCT01943578 Value of Physical Capacity Tests in Lung Cancer https://ClinicalTrials.gov/show/NCT01943578 Completed Rigshospitalet, Denmark 2014-06-30
NCT01540045 Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer https://ClinicalTrials.gov/show/NCT01540045 Completed Instituto Nacional de Cancerologia de Mexico 2011-12-31
NCT04199741 PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56 https://ClinicalTrials.gov/show/NCT04199741 Recruiting Memorial Sloan Kettering Cancer Center 2021-06-11
NCT03911219 Study to Evaluate the Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) Under 1st-line Treatment With Atezolizumab and Platinum-based Chemotherapy https://ClinicalTrials.gov/show/NCT03911219 Recruiting iOMEDICO AG 2024-06-30
NCT03896958 The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) https://ClinicalTrials.gov/show/NCT03896958 Recruiting SpeciCare 2021-03-12
NCT03741829 TS Overexpression in SCLC: Mechanism and Therapeutic Targeting https://ClinicalTrials.gov/show/NCT03741829 Completed Wake Forest University Health Sciences 2020-01-03
NCT03583528 DOTATOC PET/CT for Imaging NET Patients https://ClinicalTrials.gov/show/NCT03583528 Recruiting British Columbia Cancer Agency 2023-12-31
NCT03499678 Lung Cancer Screening Using DNA Methylation Changes in Circulated Tumor and PBMC DNA https://ClinicalTrials.gov/show/NCT03499678 Recruiting HKGepitherapeutics 2020-12-01
NCT03425825 Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT03425825 Active, not recruiting Bristol-Myers Squibb 2019-03-28
NCT03419286 Transformation Into Small Cell Lung Cancer : a Mode of Resistance to Treatment https://ClinicalTrials.gov/show/NCT03419286 Completed University Hospital, Grenoble 2017-11-30
NCT01182155 Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation https://ClinicalTrials.gov/show/NCT01182155 Completed Stanford University 2011-09-30
NCT01173458 Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC) https://ClinicalTrials.gov/show/NCT01173458 Completed University of Kansas Medical Center 2012-11-30
NCT01040312 An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors https://ClinicalTrials.gov/show/NCT01040312 Completed Daiichi Sankyo, Inc. 2014-09-29
NCT01037023 Regulatory Hycamtin(Oral) PMS https://ClinicalTrials.gov/show/NCT01037023 Completed GlaxoSmithKline 2014-11-30
NCT00997061 SCOT Registry: Small Cell Lung Cancer Treatment and Outcome https://ClinicalTrials.gov/show/NCT00997061 Completed GlaxoSmithKline 2012-02-29
NCT00923884 Prospective Analysis of Genotypes in Adults Undergoing Therapy for Lung Cancer https://ClinicalTrials.gov/show/NCT00923884 Completed National Institutes of Health Clinical Center (CC) NA
NCT00897442 Collecting Tumor Samples From Patients With Gynecological Tumors https://ClinicalTrials.gov/show/NCT00897442 Completed Gynecologic Oncology Group 2016-01-31
NCT00883181 A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy https://ClinicalTrials.gov/show/NCT00883181 Completed Amgen 2009-10-31
NCT04106167 Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy https://ClinicalTrials.gov/show/NCT04106167 Recruiting Fate Therapeutics 2034-02-28
NCT00572923 Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans https://ClinicalTrials.gov/show/NCT00572923 Completed Maastricht Radiation Oncology NA
NCT00469066 Cone Beam CT Scanning in Lung and Bladder Cancer. https://ClinicalTrials.gov/show/NCT00469066 Completed AHS Cancer Control Alberta 2009-08-31
NCT00460356 Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes https://ClinicalTrials.gov/show/NCT00460356 Completed Gynecologic Oncology Group 2016-07-16
NCT00263731 Metabolomic Analysis of Lung Cancer https://ClinicalTrials.gov/show/NCT00263731 Recruiting University of Louisville 2025-12-31
NCT00132704 An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation https://ClinicalTrials.gov/show/NCT00132704 Completed Memorial Sloan Kettering Cancer Center 2014-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients https://ClinicalTrials.gov/show/NCT02622581 Recruiting AIO-Studien-gGmbH 2023-09-30
NCT01970696 International Ovarian & Testicular Stromal Tumor Registry https://ClinicalTrials.gov/show/NCT01970696 Recruiting Children’s Hospitals and Clinics of Minnesota 2025-12-31